Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valategrast hydrochloride (R411), a dual antagonist of integrin α4β1 (VLA-4), is used for the potential treatment of asthma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | Valategrast hydrochloride (R411), a dual antagonist of integrin α4β1 (VLA-4), is used for the potential treatment of asthma. |
In vitro | Valategrast hydrochloride incorporates a prevalent l-phenylalanine-N-aroyl structure, with the carboxylic acid moiety facilitating attachment to the metal ion at the metal-ion-dependent adhesion site (MIDAS)[2]. |
Synonyms | Valategrast HCl, R411, RO0272441, RO27244, RO-27-2441, R-411, RO-0272441 |
Molecular Weight | 641.41 |
Formula | C30H33Cl4N3O4 |
CAS No. | 828271-96-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valategrast hydrochloride 828271-96-1 Cytoskeletal Signaling Integrin RO 27244 Valategrast HCl R411 RO0272441 R 411 RO-27244 RO27244 RO-27-2441 Valategrast Hydrochloride R-411 RO-0272441 RO 0272441 inhibitor inhibit